BJU International

Papers
(The H4-Index of BJU International is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Is Artificial Intelligence Ready for “Primetime” in Urology?80
Editorial Board78
Journal information78
April's reviewers of the month64
Editorial Board61
Eve's and Adam's rib for prostate cancer screening57
Building a research profile during residency55
53
49
The European Association of Urology talent incubator: bridging competencies for holistic urological care48
Recent key papers in prostate cancer42
Author Index42
April's reviewers of the month41
MRI, Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?41
A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?40
Lower urinary tract electrical sensory assessment: a systematic review and meta‐analysis39
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer38
Comparison of the effects of extrinsic compression on the drainage performance of three ureteric stents38
Association between total prostate‐specific antigen (tPSA), free/tPSA, and prostate cancer mortality35
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit33
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial32
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing32
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?31
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.331
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension30
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) and magnetic resonance imaging (MRI) to improve diagnosis of pros29
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?29
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial28
0.15832114219666